Juxtapid Drug Interactions: 233 Major, 221 Moderate
Juxtapid (Lomitapide Mesylate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Juxtapid. Always confirm against the full prescribing information.
100 interactions
Abacavir
Abacavir may increase the hepatotoxic activities of Lomitapide.
Level 2 evidence
Abiraterone
Abiraterone may increase the hepatotoxic activities of Lomitapide.
Level 2 evidence
Acalabrutinib
The metabolism of Lomitapide can be decreased when combined with Acalabrutinib.
Level 1 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Lomitapide.
Level 2 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Lomitapide.
Level 1 evidence
Acetaminophen
The metabolism of Lomitapide can be decreased when combined with Acetaminophen.
Level 1 evidence
Acitretin
Acitretin may increase the hepatotoxic activities of Lomitapide.
Level 2 evidence
Albendazole
The metabolism of Lomitapide can be decreased when combined with Albendazole.
Level 2 evidence
Alfuzosin
The metabolism of Alfuzosin can be decreased when combined with Lomitapide.
Level 1 evidence
Allopurinol
Allopurinol may increase the hepatotoxic activities of Lomitapide.
Level 2 evidence
Alpelisib
The metabolism of Lomitapide can be decreased when combined with Alpelisib.
Level 1 evidence
Alprazolam
The metabolism of Alprazolam can be decreased when combined with Lomitapide.
Level 1 evidence
Enter your NPI to unlock 32 major interactions for Juxtapid
Juxtapid (Lomitapide Mesylate) has 794 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Juxtapid (Lomitapide Mesylate) has 233 major, 221 moderate, and 340 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Juxtapid. Always confirm against the full prescribing information.